Clinical Trial Update: A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating penpulimab in combination therapy for advanced nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Penpulimab

Snippet

Sponsor: Akeso | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED